MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KAPA has $6,540K in assets. $4,491K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2707.04%
Quick Ratio
2707.04%
Cash Ratio
2256.78%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated amortization
    • Deferred offering costs
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Common stock, par value 0.001, 1...

Balance Sheets
2025-12-31
Cash and cash equivalents
4,491
Vendor advances, gross
3,271
Less accumulated amortization
2,426
Vendor advances, net
845
Prepaid expenses and other current assets
51
Total current assets
5,387
Deferred offering costs
1,091
Intangible assets, net
62
Total other assets
1,153
Total assets
6,540
Accounts payable and accrued expenses
199
Total current liabilities
199
Common stock, par value 0.001, 100,000,000 shares authorized 20,821,353 and 13,736,597 shares issued and outstanding, respectively
21
Additional paid-in capital
20,582
Accumulated deficit
-14,262
Total shareholders equity
6,341
Total liabilities and shareholders equity
6,540
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Vendor advances, gross$3,271K Cash and cashequivalents$4,491K Vendor advances, net$845K Prepaid expenses andother current assets$51K Deferred offering costs$1,091K Intangible assets, net$62K Less accumulatedamortization$2,426K Total current assets$5,387K Total other assets$1,153K Total assets$6,540K Total liabilities andshareholders equity$6,540K Total shareholdersequity$6,341K Total currentliabilities$199K Accumulated deficit-$14,262K Additional paid-in capital$20,582K Accounts payable andaccrued expenses$199K Common stock, par value0.001, 100,000,000...$21K

Kairos Pharma, LTD. (KAPA)

Kairos Pharma, LTD. (KAPA)